Xin Zhou

Xin Zhou

Auto-generated profile, based on publicly available information

Xin Zhou

Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2019 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
ZSZhe Sun
Zhe Sun
QZQiu‐Li Zhu
Qiu‐Li Zhu
YSYun Shen
Yun Shen
TYTao Yan
Tao Yan
XZXin Zhou
Xin Zhou
Increasing evidence has indicated the intimate relationship between the gastrointestinal tract and respiratory tract. The microbial ecosystem has been confirmed to share key conceptual features with gut‐lung microbiome disorder and dysregulation during chronic obstructive pulmonary disease (COPD) exacerbations. However, the dynamic changes of the gut‐lung microbiome during COPD exacerbations and its potential role in disease etiology remain poorly understood. The present study investigated the dynamic changes of gut and lung microorganisms during acute exacerbation of chronic obstructive pulmonary disease (AECOPD). A longitudinal 16S ribosomal DNA survey of the gut and lung microbiome was completed on 90 feces and sputum samples collected from 15 subjects with AECOPD at three visits, which were defined as exacerbation, seven‐day stable state. The present analysis revealed a dynamic gut‐lung microbiota, where changes appeared to be associated with exacerbation events indicative of specific exacerbation phenotypes. Antibiotic and steroid treatments appeared to have differential effects on the gut‐lung microbiome, and the microbiome was associated with disease progression, but not with severity. The abundance and diversity of the microbiome was strongly influenced by the disease progression and therapy. Using culture‐independent methods to impact the gut and lung microbiota on AECOPD may be the key to understanding the interactions between the gut and lung, highlighting its potential as a biomarker, and possibly a target for future respiratory therapeutics.

3 July 2021 in Critical Care
Verified
Journal Article
Open access
PDF file
RHRunzhi Huang
Runzhi Huang
TMTong Meng
Tong Meng
QZQiongfang Zha
Qiongfang Zha
KCKebin Cheng
Kebin Cheng
XZXin Zhou
Xin Zhou
RLRuilin Liu
Ruilin Liu
Background: The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. Objective: The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. Methods: The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the prognostic nomogram was constructed to predict the overall survival of COVID-19 patients. Additionally, the scRNA-seq data of BALF and PBMCs from COVID-19 patients were downloaded to investigate the underlying mechanism of the most important prognostic indicators in lungs and peripherals, respectively. Results: In total, 304 hospitalized adult COVID-19 patients in Wuhan Jinyintan Hospital were included in the retrospective study. CEA was the only laboratory indicator with significant difference in the univariate (P < 0.001) and multivariate analysis (P = 0.020). The scRNA-seq data of BALF and PBMCs from COVID-19 patients were downloaded to investigate the underlying mechanism of CEA in lungs and peripherals, respectively. The results revealed the potential roles of CEA were significantly distributed in type II pneumocytes of BALF and developing neutrophils of PBMCs, participating in the progression of COVID-19 by regulating the cell–cell communication. Conclusion: This study identifies the prognostic roles of CEA in COVID-19 patients and implies the potential roles of CEACAM8-CEACAM6 in the progression of COVID-19 by regulating the cell–cell communication of developing neutrophils and type II pneumocyte.

20 May 2016 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
YCYuqing Chen
Yuqing Chen
KCKewen Cheng
Kewen Cheng
XZXin Zhou
Xin Zhou
BACKGROUND:Pressure support ventilation (PSV) is a standard method for non-invasive home ventilation. A bench study was designed to compare the effectiveness of patient-ventilator inspiratory termination synchronization with automated and conventiona...

9 March 2021 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
LHLili Hou
Lili Hou
ZLZhengyu Li
Zhengyu Li
LBLuhong Bao
Luhong Bao
ZZZhiguo Zhou
Zhiguo Zhou
SLShanqun Li
Shanqun Li
MZMin Zhang
Min Zhang